UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| [X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE | ||
| SECURITIES EXCHANGE ACT OF 1934 |
or
| [ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 000-50118
VistaCare, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 06-1521534 | |
| (State or other jurisdiction of | (I.R.S. Employer Identification No.) | |
| incorporation or organization) | ||
| 4800 North Scottsdale Road, Suite 5000 | ||
| Scottsdale, Arizona | 85251 | |
| (Address of principal executive offices) | (Zip code) |
(480) 648-4545
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act), during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [ ] No
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No
As of June 30, 2003, there were outstanding 15,664,207 shares of the registrants Class A Common Stock, $0.01 par value per share.
VistaCare, Inc.
TABLE OF CONTENTS
PART I FINANCIAL INFORMATION |
2 | ||||
Item 1. Financial Statements |
2 | ||||
Condensed Consolidated Balance Sheets at December 31, 2002 and June 30, 2003 |
2 | ||||
Condensed Consolidated Statements of Operations for the three and six months
ended June 30, 2002 and June 30, 2003 |
3 | ||||
Condensed Consolidated Statements of Cash Flows for the six months ended June
30, 2002 and June 30, 2003 |
4 | ||||
Notes to Condensed Consolidated Financial Statements |
5 | ||||
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations |
13 | ||||
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
33 | ||||
Item 4. Controls and Procedures |
33 | ||||
PART II OTHER INFORMATION |
34 | ||||
Item 1. Legal Proceedings |
34 | ||||
Item 2. Changes in Securities and Use of Proceeds |
34 | ||||
Item 3. Defaults Upon Senior Securities |
34 | ||||
Item 4. Submission of Matters to a Vote of Security Holders |
34 | ||||
Item 5. Other Information |
35 | ||||
Item 6. Exhibits and Reports on Form 8-K |
35 | ||||
SIGNATURES |
36 | ||||
EXHIBIT INDEX |
37 | ||||
PART I FINANCIAL INFORMATION
Item 1. Financial Statements.
VISTACARE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
| December 31, | June 30, | ||||||||||
| 2002 | 2003 | ||||||||||
| (unaudited) | |||||||||||
| (In thousands, except | |||||||||||
| share related amounts) | |||||||||||
ASSETS |
|||||||||||
Current assets: |
|||||||||||
Cash and cash equivalents |
$ | 39,104 | $ | 44,534 | |||||||
Patient accounts receivable |
19,075 | 18,867 | |||||||||
Patient accounts receivable room & board |
7,613 | 10,006 | |||||||||
Prepaid expenses and other current assets |
1,312 | 2,545 | |||||||||
Total current assets |
67,104 | 75,952 | |||||||||
Equipment, net |
2,612 | 3,344 | |||||||||
Goodwill, net of amortization |
20,564 | 20,564 | |||||||||
Other assets |
4,663 | 7,898 | |||||||||
Total assets |
$ | 94,943 | $ | 107,758 | |||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
|||||||||||
Current liabilities: |
|||||||||||
Accounts payable |
$ | 2,288 | $ | 1,424 | |||||||
Accrued expenses |
22,982 | 27,142 | |||||||||
Current portion of long-term debt |
250 | 250 | |||||||||
Current portion of capital lease obligations |
82 | 78 | |||||||||
Total current liabilities |
25,602 | 28,894 | |||||||||
Capital lease obligations, less current portion |
94 | 56 | |||||||||
Deferred tax liability |
| 1,437 | |||||||||
Stockholders equity: |
|||||||||||
Class A Common Stock, $0.01 par value;
authorized 33,000,000 shares; 15,420,899
and 15,664,207 shares issued and
outstanding at December 31, 2002 and June
30, 2003, respectively |
154 | 157 | |||||||||
Class B Common Stock, $0.01 par value;
authorized 200,000 shares; 58,096 shares
issued and outstanding at December 31, 2002
and none issued and outstanding at June 30, 2003 |
1 | | |||||||||
Additional paid-in capital |
101,161 | 101,310 | |||||||||
Deferred compensation |
(2,552 | ) | (1,225 | ) | |||||||
Accumulated deficit |
(29,517 | ) | (22,871 | ) | |||||||
Total stockholders equity |
69,247 | 77,371 | |||||||||
Total liabilities and stockholders equity |
$ | 94,943 | $ | 107,758 | |||||||
See accompanying notes to condensed consolidated financial statements.
2
VISTACARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
(In thousands, except share related
information)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||
| 2002 | 2003 | 2002 | 2003 | ||||||||||||||
Net patient revenue |
$ | 31,000 | $ | 46,050 | $ | 58,674 | $ | 88,050 | |||||||||
Operating expenses: |
|||||||||||||||||
Patient care |
18,710 | 27,713 | 35,979 | 51,799 | |||||||||||||
General and administrative
expenses, exclusive of stock-based
compensation charges reported below |
10,075 | 13,142 | 18,988 | 26,493 | |||||||||||||
Depreciation and amortization |
303 | 370 | 574 | 714 | |||||||||||||
Stock-based compensation |
88 | 102 | 137 | 1,149 | |||||||||||||
Total operating expenses |
29,176 | 41,327 | 55,678 | 80,155 | |||||||||||||
Operating income |
1,824 | 4,723 | 2,996 | 7,895 | |||||||||||||
Non-operating (expense) income: |
|||||||||||||||||
Interest income |
| 108 | 2 | 209 | |||||||||||||
Interest expense |
(204 | ) | (29 | ) | (405 | ) | (77 | ) | |||||||||
Other expense |
(39 | ) | (36 | ) | (67 | ) | (51 | ) | |||||||||
Total non-operating (expense) income |
(243 | ) | 43 | (470 | ) | 81 | |||||||||||
Net income before income taxes |
1,581 | 4,766 | 2,526 | 7,976 | |||||||||||||
Income tax expense |
65 | 944 | 101 | 1,330 | |||||||||||||
Net income |
1,516 | 3,822 | 2,425 | 6,646 | |||||||||||||
Accrued preferred stock dividends |
1,032 | | 2,065 | | |||||||||||||
Net income to common stockholders |
$ | 484 | $ | 3,822 | $ | 360 | $ | 6,646 | |||||||||
Net income per common share: |
|||||||||||||||||
Basic net income per common share |
$ | 0.09 | $ | 0.24 | $ | 0.07 | $ | 0.43 | |||||||||
Diluted net income per common share |
$ | 0.08 | $ | 0.23 | $ | 0.06 | $ | 0.40 | |||||||||
Weighted average shares outstanding: |
|||||||||||||||||
Basic |
5,110 | 15,633 | 5,105 | 15,595 | |||||||||||||
Diluted |
6,022 | 16,913 | 5,874 | 16,800 | |||||||||||||
See accompanying notes to condensed consolidated financial statements.
3
VISTACARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Six Months Ended | ||||||||||
| June 30, | ||||||||||
| 2002 | 2003 | |||||||||
| (unaudited) | ||||||||||
| (In thousands) | ||||||||||
Operating activities |
||||||||||
Net income |
$ | 2,425 | $ | 6,646 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||
Depreciation and amortization |
574 | 714 | ||||||||
Warrant amortization |
76 | | ||||||||
Deferred compensation related to stock options |
137 | 1,149 | ||||||||
Loss on disposal of assets |
| 23 | ||||||||
Changes in operating assets and liabilities: |
||||||||||
Patient accounts receivable |
(822 | ) | (2,185 | ) | ||||||
Prepaid expenses and other |
(383 | ) | (3,296 | ) | ||||||
Accounts payable and accrued expenses |
923 | 4,692 | ||||||||
Net cash provided by operating activities |
2,930 | 7,743 | ||||||||
Investing activities |
||||||||||
Purchases of equipment |
(541 | ) | (1,178 | ) | ||||||
Increase in other assets |
(963 | ) | (1,463 | ) | ||||||
Net cash used in investing activities |
(1,504 | ) | (2,641 | ) | ||||||
Financing activities |
||||||||||
Net payments on long-term debt |
(818 | ) | | |||||||
Cost associated with common stock offering |
| (191 | ) | |||||||
Proceeds from issuance of common stock from exercise of stock options |
74 | 519 | ||||||||
Net cash (used in) provided by financing activities |
(744 | ) | 328 | |||||||
Net increase in cash and cash equivalents |
682 | 5,430 | ||||||||
Cash and cash equivalents, beginning of period |
1,384 | 39,104 | ||||||||
Cash and cash equivalents, end of period |
$ | 2,066 | $ | 44,534 | ||||||
Non
cash activity |
||||||||||
Preferred
stock dividends |
$ | 2,065 | $ | | ||||||
See accompanying notes to condensed consolidated financial statements.
4
VISTACARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Description of Business
VistaCare, Inc. (VistaCare), is a Delaware corporation providing medical care designed to address the physical, emotional, and spiritual needs of patients with a terminal illness and to support their family members. Hospice services are provided predominately in the patients home; however, certain patients require inpatient services. These inpatient services are provided by VistaCare at its stand-alone inpatient facility in Cincinnati, Ohio, at its hospital-based inpatient facility in Albuquerque, New Mexico or through leased beds at other unrelated hospitals and skilled nursing facilities on a per diem basis. VistaCare provides services in Alabama, Arizona, Colorado, Georgia, Indiana, Massachusetts, New Mexico, Nevada, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas and Utah.
1. Significant Accounting Policies
Basis of Presentation
The accompanying condensed consolidated financial statements include accounts of VistaCare and its wholly-owned subsidiaries: VistaCare USA, Inc., Vista Hospice Care, Inc., and FHI Health Services, Inc. (including its wholly-owned subsidiaries). Intercompany transactions and balances have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the six-month period ended June 30, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003.
The balance sheet at December 31, 2002 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in VistaCares annual report on Form 10-K for the year ended December 31, 2002.
Capitalized Software Development Costs
VistaCare capitalizes certain internal salaries related to the development of computer software used in its operations. Such capitalized software development costs are being amortized over three years. Capitalized software development costs, net of amortization, included in other assets, amounted to $3,965,000 at December 31, 2002 and $4,899,000 at June 30, 2003. Costs incurred during the preliminary project stage and post implementation/operations stage are expensed as incurred.
Goodwill
During 1998, VistaCare completed the acquisitions of FHI Health Services, Inc. and Vencor Hospice, Inc. (VistaCare USA, Inc.). During 2002, VistaCare completed the acquisition of Palliative Care Concepts, Inc. The difference between the purchase prices and the fair value of assets acquired and liabilities assumed was recorded as goodwill. Prior to January 1, 2002, VistaCare amortized goodwill over a period of 30 years. Amortization related to goodwill totaled $2,408,000 on January 1, 2002 and 2003. No amortization was recognized in the six-months ended June 30, 2002 and 2003.
In June 2001, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets,
5
which became effective for VistaCare in the first quarter of 2002. Under these rules, goodwill and intangible assets deemed to have indefinite lives are no longer amortized but are subject to impairment tests that must be conducted at least annually, or more often if events or circumstances arise that indicate that the carrying value of the goodwill associated with VistaCares acquired businesses exceeds its fair market value. VistaCare determined that no impairment of goodwill existed at December 31, 2002 or at June 30, 2003.
Acquisition
In August 2002, VistaCare completed the acquisition of Palliative Care Concepts, Inc., a hospice program in Albuquerque, New Mexico. VistaCare paid $2,500,000 in cash and issued a $250,000 unsecured promissory note to the seller in connection with the acquisition. The purchase price was allocated primarily to goodwill. The promissory note was paid in full in July 2003.
Net Patient Revenue
Net patient revenue is the amount VistaCare believes it is entitled to collect for its services, adjusted as described below. The amount VistaCare believes it is entitled to collect for its services varies depending on the level of care provided, the payor and the geographic area where services are rendered. Net patient revenue includes adjustments for charity care and estimated payment denials (which VistaCare experiences from time to time for reasons such as its failure to submit complete and accurate claim documentation, its failure to provide timely written physician certifications as to patient eligibility, or the payor deems the patient ineligible for insurance coverage), contractual adjustments, amounts VistaCare estimates it could be required to repay to Medicare, such as payments that VistaCare would be required to make in the event that any of its programs exceed the annual per-beneficiary cap, and subsequent changes to initial level of care determinations. VistaCare adjusts its estimates from time to time based on its billing and collection experience. VistaCare believes that it can reasonably estimate such adjustments to net patient revenue because it has significant historical experience and because it has a centralized billing and collection department that continually monitors the factors that could potentially result in a change in estimate. There were no material changes in estimates to net patient revenue for the year ended December 31, 2002 or the six-month periods ended June 30, 2002 and 2003. VistaCare recognizes net patient revenue once the patients hospice eligibility has been certified, the patients coverage from a payment source has been verified and services have been provided to that patient.
Approximately 95% and 96% of VistaCares net patient revenue was derived from the Medicare and Medicaid programs for the six-month periods ended June 30, 2002 and 2003, respectively. VistaCare operates under arrangements with Medicare, Medicaid and other third-party payors pursuant to which these payors reimburse VistaCare for services it provides to hospice-eligible patients these payors cover, subject only to VistaCares submission of adequate and timely claim documentation. VistaCare has a patient intake process that screens patients for hospice eligibility and identifies whether their care will be covered by Medicare, Medicaid, private insurance, managed care or self-pay. Whether Medicare or Medicaid continue to provide reimbursement for hospice care is dependent upon governmental policies.
Medicare and Medicaid Regulation
VistaCare is subject to certain limitations on Medicare payments for services. Specifically, if the number of inpatient care days of care any hospice program provides to Medicare beneficiaries exceeds 20% of the total days of hospice care such program provides to all patients for an annual period beginning September 28, the days in excess of the 20% figure may be reimbursed only at the routine home care rate. None of VistaCares hospice programs exceeded the payment limits on inpatient services in the six-month periods ended June 30, 2002 or 2003.
VistaCare is also subject to a Medicare annual per-beneficiary cap. Compliance with the Medicare per-beneficiary cap is measured by comparing the cost of services provided to each Medicare beneficiary by each hospice program during the Medicare fiscal year ending October 31 to the per-beneficiary cap amount for each Medicare beneficiary in such program who elects to receive the Medicare hospice benefit for the first time during such fiscal year. VistaCare recorded reductions to net patient revenue of approximately $1,262,000 for the eight months ended June 30, 2003 as estimates for exceeding the Medicare per-beneficiary cap for the 2003 fiscal cap year that began on November 1, 2002. VistaCare did not record any reduction to net patient revenue for the eight months ended June 30, 2002 as an estimate for exceeding the per-
6
beneficiary cap for the 2002 fiscal cap year that began November 1, 2001. As of the date of this report, VistaCare had not been assessed any amounts for exceeding the per-beneficiary cap for the assessment periods that began on November 1, 2001 and November 1, 2002. VistaCare management believes that as of June 30, 2003 adequate reserves had been established for this potential liability.
VistaCare monitors each of its programs to determine whether such programs are likely to exceed the foregoing limitations and estimates the extent to which it could be required to repay Medicare. At the time that management estimates the potential impact of having exceeded the Medicare limitations, the estimated assessment is deducted from net patient revenue and accrued as an accrued expense.
Laws and regulations governing the Medicare and Medicaid program are complex and subject to interpretation. VistaCare believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing, which would have a material impact on VistaCares consolidated financial condition, or results of operations. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare and Medicaid programs.
Charity Care
VistaCare provides care at no cost to patients who are not eligible for insurance coverage and meet certain financial need criteria established by VistaCare. Charity care totaled approximately $305,000 and $722,000 for the three months ended June 30, 2002 and 2003, respectively, and $818,000 and $1,388,000 for the six months ended June 30, 2002 and 2003, respectively. Because VistaCare does not pursue collection of amounts determined to qualify as charity care, these amounts are not recorded in net patient revenue. Costs VistaCare incurs in providing charity care are recorded as patient care expenses.
Nursing Home Costs
For patients receiving nursing home care under state Medicaid programs who elect hospice care under Medicare or Medicaid, VistaCare contracts with nursing homes for the nursing homes provision to patients of room and board services. In most states, the applicable Medicaid program must pay VistaCare, in addition to the applicable Medicare or Medicaid hospice daily or hourly rate, an amount equal to at least 95% of the Medicaid daily nursing home rate for room and board furnished to the patient by the nursing home. In some states, the Medicaid program pays the nursing home directly for these costs or has created a Medicare managed care program that either reduces or eliminates this room and board payment. Under VistaCares standard nursing home contracts, VistaCare pays the nursing home for these room and board services at predetermined contract rates. Nursing home costs are offset by nursing home revenue and the net amount is included in patient care expenses.
Nursing home costs totaled approximately $6,351,000 and $7,623,000 for the three months ended June 30, 2002 and 2003, respectively, and $10,002,000 and $15,108,000 for the six months ended June 30, 2002 and 2003, respectively. Nursing home revenue totaled approximately $6,014,000 and $7,191,000 for the three months ended June 30,2002 and 2003, respectively, and $9,505,000 and $14,307,000 for the six months ended June 30, 2002 and 2003, respectively.
Income Taxes
VistaCare accounts for income taxes under the liability method as required by SFAS No. 109, Accounting for Income Taxes. Under the liability method, deferred taxes are determined based on temporary differences between financial statement and tax bases of assets and liabilities existing at each balance sheet date using enacted tax rates for years in which the related taxes are expected to be paid or recovered.
Medical Malpractice
VistaCare is covered by claims-made general and professional liability insurance coverage with limits of $1,000,000 per claim and $3,000,000 in the aggregate. VistaCare has not experienced any uninsured medical
7
malpractice losses.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Stock-Based Compensation
VistaCare has elected to follow Accounting Principles Board Opinion No. 25 (APB No. 25), Accounting for Stock Issued to Employees and related interpretations, in accounting for its employee stock options rather than the alternative fair value accounting allowed by SFAS No. 123 (SFAS 123), Accounting for Stock-Based Compensation. Under APB No. 25, if the exercise price of VistaCares stock options equals or exceeds the estimated fair value of the underlying stock on the dates of grant, no compensation expense is recognized. However, if the exercise prices of VistaCares stock options are less than the estimated fair value, on the date of grant, then compensation expense will be recognized for the difference over the related vesting periods.
If compensation for options granted under VistaCares stock option plan had been determined based on the deemed fair value at the grant date consistent with the method provided under SFAS 123, then VistaCares net income would have been as indicated in the pro forma table below (in thousands, except share related information).
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||
| 2002 | 2003 | 2002 | 2003 | ||||||||||||||
Net income to common stockholders: |
|||||||||||||||||
As reported: |
$ | 484 | $ | 3,822 | $ | 360 | $ | 6,646 | |||||||||
Add: Stock-based employee
compensation expense included
in reported net income, net of
related tax effects |
88 | 102 | 137 | 1,149 | |||||||||||||
Deduct: Total stock-based
compensation expense determined
under fair value method for all
awards |
(132 | ) | (831 | ) | (277 | ) | (1,618 | ) | |||||||||
Pro forma net income to
common stockholders |
$ | 440 | $ | 3,093 | $ | 220 | $ | 6,177 | |||||||||
Basic
net income per common share: |
|||||||||||||||||
As reported |
$ | 0.09 | $ | 0.24 | $ | 0.07 | $ | 0.43 | |||||||||
Pro forma |
0.09 | 0.20 | 0.04 | 0.40 | |||||||||||||
Diluted
net income per common share: |
|||||||||||||||||
As reported |
$ | 0.08 | $ | 0.23 | $ | 0.06 | $ | 0.40 | |||||||||
Pro forma |
0.07 | 0.18 | 0.04 | 0.37 | |||||||||||||
Weighted average shares used in computation: |
|||||||||||||||||